Alnylam Pharmaceuticals
ALNY
#546
Rank
โ‚น4.110 T
Marketcap
โ‚น31,117
Share price
-2.13%
Change (1 day)
31.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company